publication venue for
- Framing harm reduction as part of an integrated approach to reduce drug overdose: A randomized message testing experiment in a nationally representative sample of U.S. adults, 2022.. 118. 2023
- Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.. 109. 2022
- Association between U.S. state prenatal drug use laws and child welfare reporting in Alabama, Maryland and Utah.. 108. 2022
- Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.. 99. 2021
- Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.. 98. 2021
- Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis.. 84. 2020
- Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions.. 76. 2020
- Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.. 72. 2019
- Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination.. 72. 2019
- The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.. 67. 2019
- Arguments supporting and opposing legalization of safe consumption sites in the U.S.. 63. 2018
- An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.. 26. 2015